LINC01804

Across TCGA pan-cancer cohorts, LINC01804 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01804’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01804 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01804 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

THCA, LUAD, and COAD are the cancer types where LINC01804 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01804 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.089	<.001	9	view →
LUAD	All	All	+0.212	.002	6	view →
COAD	All	II,III,IV	−0.013	.003	4	view →
KICH	Male	All	−0.015	.010	3	view →
KIRC	Male	IV	−0.006	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01804–THCA

Open the THCA breakdown →